HomeNewsBusinessEarningsBuy Ambuja Cement; target of Rs 718: Prabhudas Capital

Buy Ambuja Cement; target of Rs 718: Prabhudas Capital

Prabhudas Capital is bullish on Ambuja Cement has recommended buy rating on the stock with a target price of Rs 718 in its research report dated November 04, 2025.

November 05, 2025 / 14:53 IST
Story continues below Advertisement
buy
buy

Prabhudas Capital's research report on Ambuja Cement

Ambuja Cements (ACEM) delivered a strong cons operating performance in Q2FY26 with 20% YoY volume growth (16.6mt ex-clinker), driven by ramp up of recently acquired assets. Cement NSR declined 1% QoQ due to softer prices during the quarter. ACEM benefited from higher contribution from 100% integration of Orient & Penna volumes into Adani brands as major maintenance is also completed. Decline in RM costs due to lower purchase of goods and improved logistics efficiencies resulted in ACEM delivering EBITDA/t of Rs 1,045 (Rs 1,060 ex-clinker). Mgmt. reiterated its focus on cost optimization, targeting exit FY26 cost of Rs 4,000/t and further reduction by 5% each year to Rs 3,650/t by FY28 end, driven by higher green power usage (c. 33% share, target 60%) and group synergy benefits.

Story continues below Advertisement

Outlook

Integration of acquired assets has been largely completed along with major maintenance which is expected to drive volumes and profitability. Although there are delays in organic expansion, ACEM has enough capacity to grab incremental market share (c. CU% 65%). With planned aggressive capacity expansion and consistent efforts to engage pan-India dealer & retailer network, ACEM is well poised to outpace industry growth. We remain positive on ACEM as it continues to strengthen its cost competitiveness, scale, and market leadership. We tweak our estimates assuming lower prices in near term and expect ACEM to deliver 14% volume CAGR and 26% EBITDA CAGR over FY25–28E. Stock is trading at EV of 14.7x/12.5x FY27/28E EBITDA. Maintain ‘Buy’ with revised TP of Rs 718 (Rs 701 earlier) valuing at 17x EV of Sep’27E EBITDA.